Figure 6.
Decision curve analysis of the nomogram and AJCC tumor staging. (A) 3-year survival benefit in the training cohort. (B) 3-year survival benefit in the validation cohort. (C) 6-year survival benefit in the training cohort. (D) 6-year survival benefit in the validation cohort. (E) 9-year survival benefit in the training cohort. (F) 9-year survival benefit in the validation cohort.